Index AR1 - Anticancer Research

More documents

Recommendations

Info

ANTICANCER RESEARCH 28: Index (2008) Positive Correlation between Cyclooxygenase 2 and the Expression of ABC Transporters in Non-small Cell Lung Cancer. P. SUROWIAK, K. PAWEŁCZYK, A. MACIEJCZYK, M. PUDEŁKO, J. KOŁODZIEJ, M. ZABEL, D. MURAWA, M. DRAG, T. GANSUKH, M. DIETEL, H. LAGE (Berlin, Germany; Wrocław; Poznań, Poland; Ulan Bator, Mongolia; La Jolla, CA, USA) .................................................................................................................................. Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer. R. KLOTZ, A.G. ZEIMET, D. REIMER, E. MÜLLER-HOLZNER, M. CHAMSON, C. MARTH (Innsbruck, Austria)..................................... TUNEL as a Tumor Marker of Tongue Cancer. O. BEN-IZHAK, Z. LASTER, S. AKRISH, G. COHEN, R.M. NAGLER (Haifa; Poriya, Tiberias, Israel)........................................................................................................................ Oxaliplatin-eluting Microspheres for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Report. G. POGGI, P. QUARETTI, C. MINOIA, I. PALUMBO, L. VILLANI, A. AMATU, C. TERAGNI, M. SCELSI, F. ZAPPOLI, G. BERNARDO (Pavia, Italy) ........................................................................................................................... Expression and Prognostic Significance of PDCD4 in Human Epithelial Ovarian Carcinoma. X. WANG, Z. WEI, F. GAO, X. ZHANG, C. ZHOU, F. ZHU, Q. WANG, Q. GAO, C. MA, W. SUN, B. KONG, L. ZHANG (Jinan, Shandong, P. R. China).................................................................................................................................................................... * The Role of Podoplanin in Tumor Progression and Metastasis. M. RAICA, A.M. CIMPEAN, D. RIBATTI (Timisoara, Romania; Bari, Italy)................................................................................................................................................... Occult Prostate Cancer Effects the Results of Case-Control Studies Due to Verification Bias. T. IGUCHI, C.Y. WANG, N.B. DELONGCHAMPS, R. SUNHEIMER, T. NAKATANI, G. DE LA ROZA, G.P. HAAS (Syracuse, NY, USA; Osaka, Japan)............................................................................................................................................... Pleomorphic Adenoma of Salivary Glands Does Not Appear to Be a BRCA-1-dependent Tumour in a Polish Cohort. J. LUBIŃSKI, C. TARNOWSKA, E. JAWOROWSKA, T. BYRSKI, A. JAKUBOWSKA, B. GÓRSKI, S. BIEŃ, J. SYGUT, S. GÓŹDŹ, M. SIOŁEK, M. SULIKOWSKI, J. LUBIŃSKI (Szczecin; Kielce, Poland).......... Validation of the Graded Prognostic Assessment Index for Surgically Treated Patients with Brain Metastases. C. NIEDER, H. GEINITZ, M. MOLLS (Bodø; Tromsø, Norway; Munich, Germany)................................................... Gefitinib in Combination with Gemcitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pre-treated with Taxane and Anthracycline Chemotherapy: A Phase I/II Trial. I. GIOULBASANIS, Z. SARIDAKI, A. KALYKAKI, L. VAMVAKAS, K. KALBAKIS, M. IGNATIADIS, K. AMARANTIDIS, S. KAKOLYRIS, V. GEORGOULIAS, D. MAVROUDIS (Heraklion, Alexandroupolis, Greece) .............................................................. ProGRP and NSE in Therapy Monitoring in Patients with Small Cell Lung Cancer. E. WÓJCIK, J.K. KULPA, B. SAS-KORCZYŃSKA, S. KORZENIOWSKI, J. JAKUBOWICZ (Cracow, Poland)............................................... Hypofractionated Accelerated Radiotherapy, Cytoprotection and Capecitabine in the Treatment of Rectal Cancer: A Feasibility Study. M.I. KOUKOURAKIS, C. SIMOPOULOS, M. PITIAKOUDIS, N. LYRATZOPOULOS, K. ROMANIDIS, A. GIATROMANOLAKI, A. POLYCHRONIDIS, G. KOUKLAKIS, E. SIVRIDIS, G. MINOPOULOS, K. MANOLAS (Alexandroupolis, Greece)............................................................................................ Adriamycin, Cisplatin, Ifosfamide and Paclitaxel Combination as Front-line Chemotherapy for Locally Advanced and Metastatic Angiosarcoma. Analysis of Three Case Reports and Review of the Literature. I. ASMANE, V. LITIQUE, S. HEYMANN, L. MARCELLIN, A.-C. MÉTIVIER, B. DUCLOS, J.-P. BERGERAT, J.-E. KURTZ (Strasbourg, France) ............................................................................................................................................... Breast Metastasis 56 Months before the Diagnosis of Primary Ovarian Cancer: A Case Study. S.E. SCHNEUBER, H.S. SCHOLZ, P. REGITNIG, E. PETRU, R. WINTER (Graz, Austria) ....................................................................... 2967 2975 2981 2987 2991 2997 3007 3011 3015 3019 3027 3035 3041 3047 4213
ANTICANCER RESEARCH 28: Index (2008) Toxic Encephalopathy and Delayed MTX Clearance after High-dose Methotrexate Therapy in a Child Homozygous for the MTHFR C677T Polymorphism. J. MÜLLER, J. KRALOVÁNSZKY, V. ADLEFF, É. PAP, K. NÉMETH, V. KOMLÓSI, G. KOVÁCS (Budapest, Hungary) ....................................................................................... Gemcitabine and Protracted 5-Fluorouracil Infusion as Third-line Chemotherapy in Refractory Colorectal Cancer Patients. R. BITOSSI, C.M. SCULLI, M. TAMPELLINI, I. ALABISO, M.P. BRIZZI, A. FERRERO, A. OTTONE, E. BELLINI, G. GORZEGNO, A. BERRUTI, L. DOGLIOTTI (Orbassano, Torino, Italy) ........... Procalcitonin as a Useful Marker of Infection in Hemato-oncological Patients with Fever. M.T. SANDRI, R. PASSERINI, M.E. LEON, F.A. PECCATORI, L. ZORZINO, M. SALVATICI, D. RIGGIO, C. CASSATELLA, S. CINIERI, G. MARTINELLI (Milan; Brindisi, Italy) ..................................................................... Evaluation of a Manual ELISA Kit for Determination of HER2/neu in Serum of Breast Cancer Patients. ANNE- SOPHIE GAUCHEZ, NADIA RAVANEL, DANIÈLE VILLEMAIN, FRAN∏OIS-XAVIER BRAND, DOMINIQUE PASQUIER, RAOUL PAYAN, MIREILLE MOUSSEAU (Grenoble; Saint-Martin d’Hères, France)................................................................................................................................................................................................. Evaluation of Fixed Dosing of New Anticancer Agents in Phase I Studies. D. LEVÊQUE (Strasbourg, France).... Association Between Genetic Polymorphisms and Ovarian Cancer Risk. L. DELORT, N. CHALABI, S. SATIH, N. RABIAU, F. KWIATKOWSKI, Y.-J. BIGNON, D.J BERNARD-GALLON (Clermont-Ferrand; France)....... Primary Uterine Leiomyosarcoma and Primary Atypical Meningioma Diagnosed during Pregnancy. B. BODNER- ADLER, P. LOZANO, K. BODNER, H. ZEISLER (Vienna, Austria)............................................................................. Bevacizumab Added to the Irinotecan and Capecitabine Combination for Advanced Colorectal Cancer: A Welltolerated, Active and Convenient Regimen. A. ARDAVANIS, P. KOUNTOURAKIS, I. MANTZARIS, S. MALLIOU, D. DOUFEXIS, D. SYKOUTRI, I. FRAGOS, G. RIGATOS (Athens, Greece)................................ Neoadjuvant Chemotherapy with Vinorelbine-containing Regimens in Elderly Patients with Locally Advanced Breast Cancer. C.-D. MA, C.-M. CHEN, X.-S. CHEN, G.-Y. LIU, G.-H. DI, J. WU, J.-S. LU, W.-T. YANG, J.-Y. CHEN, Z.-M. SHAO, Z.-Z. SHEN, K.-W. SHEN (Shanghai, P.R. China) ............................................................. Safety of Nab-paclitaxel plus Sunitinib: Analysis of Three Cases. A.Z. DUDEK, S. NGUYEN (Minneapolis, MN, USA)..................................................................................................................................................................................................... Von Recklinghausen’s Disease Associated with Malignant Peripheral Nerve Sheath Tumor Presenting with Constipation and Urinary Retention: A Case Report and Review of the Literature. P. KARATZOGLOU, A. KARAGIANNIDIS, J. KOUNTOURAS, C.V. CHRISTOFIRIDIS, M. KARAVALAKI, C. ZAVOS, E. GAVALAS, K. PATSIAOURA, N. VOUGIOUKLIS (Thessaloniki, Greece)............................................................ Fatal Thrombocytopenia after Oxaliplatin-based Chemotherapy. Y.-Y. SHAO, R.-L. HONG (Taipei, Taiwan, ROC).................................................................................................................................................................................................... Protective Effect of Cox-2 Allelic Variants on Risk of Colorectal Adenoma Development in African Americans. H. ASHKTORAB, S. TSANG, B. LUKE, Z. SUN, L. ADAM-CAMPBELL, J. KWAGYAN, R. POIRIER, S. AKTER, A. AKHGAR, D. SMOOT, D.J. MUNROE, I.U. ALI (Washington, DC; Frederick, MD; Bethesda, MD, USA) ........................................................................................................................................................................................... Telomerase Activity in Head and Neck Cancer. Z. KUNICKÁ, I. MUCHA, J. FAJKUS (Brno, Czech Republic) ..... Endocervical Cytobrush for the Detection of Cervical Dysplasia Before Large Loop Excision of the Transformation Zone (LLETZ). C. TEMPFER, S. POLTERAUER, C. GRIMM, E.-K. BENTZ, A. REINTHALLER, L.A. HEFLER (Vienna, Austria).......................................................................................................... 4214 3051 3055 3061 3067 3075 3079 3083 3087 3093 3099 3107 3115 3119 3125 3131
Page 1 and 2: ANTICANCER RESEARCH International J
Page 3 and 4: Editorial Board ANTICANCER RESEARCH
Page 5 and 6: ANTICANCER RESEARCH 28: Index (2008
Page 7 and 8: Department of Health, Executive Yua
Page 9 and 10: National R&D Program for Cancer Con
Page 11 and 12: Number 1A Experimental Studies ANTI
Page 15 and 16: * ANTICANCER RESEARCH 28: Index (20
Page 17 and 18: Amelanotic Metastasis of Melanoma M
Page 23 and 24: * ANTICANCER RESEARCH 28: Index (20
Page 25 and 26: Detection of Oncogenic DNA Viruses
Page 27 and 28: Gross Thymic Extract, Thymax, Induc
Page 31 and 32: * Number 4A Special Issue on Prosta
Page 37 and 38: Adjuvant Treatment for Elderly Pati
Page 41: ANTICANCER RESEARCH 28: Index (2008
Page 45 and 46: * * ANTICANCER RESEARCH 28: Index (
Page 47 and 48: Number 6B Clinical Studies ANTICANC
Page 49 and 50: Abstracts of the 14th International
Page 51 and 52: Aggrecan, versican, decorin, Wester
Page 53 and 54: Apoptosis, inotodiol, lanostane tri
Page 55 and 56: Bone metastases, bisphosphonates, z
Page 57 and 58: Capecitabine, colorectal cancer, ir
Page 59 and 60: Chemoresistance, cancer of unknown
Page 61 and 62: Colorectal adenoma, Cox-2 polymorph
Page 63 and 64: Cytotoxicity, ferrocene, β-diketon
Page 65 and 66: Electrochemiluminescence immunoassa
Page 67 and 68: Ferrocene, β-diketone, cytotoxicit
Page 69 and 70: Genistein, soy extract, MDA-MB-231
Page 71 and 72: Histone deacetylase inhibitor, vita
Page 73 and 74: Infusion, 5-fluorouracil, arterial,
Page 75 and 76: Liver metastasis, pioglitazone, col
Page 77 and 78: Melphalan, hyperthermia, apoptosis,
Page 79 and 80: Mucin, adenocarcinoma, metastatic b
Page 81 and 82: Oesophageal cancer, carboplatin, el
Page 83 and 84: P53, syndecan-1, tenascin-C, TATI,
Page 85 and 86: Plumbagin, apoptosis, pro-apoptotic
Page 87 and 88: ProGRP, small cell lung cancer, NSE
Page 89 and 90: RA-resistance, leukemia cells, reti
Page 91 and 92: S-1, cisplatin, advanced pancreatic
Page 93 and 94:
Sonic hedgehog, breast cancer, estr
Page 95 and 96:
Thrombosis, gynecological cancer, c
Page 97 and 98:
Type of cell death, β-cyclodextrin
Page 99 and 100:
Authors Index (Figures refer to pag
Page 101 and 102:
Cho S-H, 2649 Choi MS, 3777 Chorti
Page 103 and 104:
Giuliani L, 1405 Goda T, 2343 Goess
Page 105 and 106:
Katano M, 731, 2401 Katayama K, 847
Page 107 and 108:
Mahajan A, 741 Maiti A, 3705 Majka
Page 109 and 110:
Onogawa T, 2669 Onouchi S, 145 Onoz
Page 111 and 112:
Scotti M, 1951 Sculli CM, 3055 Seco
Page 113 and 114:
Usami M, 3913 Ushijima R, 601 Usui
Page 115 and 116:
Errata ANTICANCER RESEARCH 28: Inde
Page 117 and 118:
Medicherla et al: TGF-‚ Inhibitor
Page 119 and 120:
Volume 28 (2008), No 2A, page 1072:
Page 121:
Publication Data: ANTICANCER RESEAR
show all

Index AR1 - Anticancer Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?